Cambridge Investment Research Advisors
PFE icon

Cambridge Investment Research Advisors’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$46.1M Buy
1,901,502
+121,272
+7% +$2.94M 0.14% 130
2025
Q1
$45.1M Buy
1,780,230
+64,277
+4% +$1.63M 0.15% 127
2024
Q4
$45.5M Sell
1,715,953
-31,803
-2% -$844K 0.15% 121
2024
Q3
$50.6M Sell
1,747,756
-28,849
-2% -$835K 0.17% 108
2024
Q2
$49.7M Buy
1,776,605
+75,444
+4% +$2.11M 0.18% 101
2024
Q1
$47.2M Buy
1,701,161
+111,509
+7% +$3.09M 0.18% 99
2023
Q4
$45.8M Buy
1,589,652
+136,467
+9% +$3.93M 0.2% 91
2023
Q3
$48.2M Sell
1,453,185
-93,885
-6% -$3.11M 0.23% 83
2023
Q2
$56.7M Buy
1,547,070
+225,184
+17% +$8.26M 0.26% 64
2023
Q1
$53.9M Sell
1,321,886
-42,836
-3% -$1.75M 0.26% 65
2022
Q4
$69.9M Sell
1,364,722
-2,157
-0.2% -$111K 0.36% 51
2022
Q3
$59.8M Sell
1,366,879
-19,404
-1% -$849K 0.34% 54
2022
Q2
$72.7M Buy
1,386,283
+7,162
+0.5% +$376K 0.39% 48
2022
Q1
$71.4M Sell
1,379,121
-161,010
-10% -$8.34M 0.33% 55
2021
Q4
$90.9M Buy
1,540,131
+76,914
+5% +$4.54M 0.41% 40
2021
Q3
$62.9M Sell
1,463,217
-126,671
-8% -$5.45M 0.31% 56
2021
Q2
$62.3M Buy
1,589,888
+105,200
+7% +$4.12M 0.3% 58
2021
Q1
$53.8M Sell
1,484,688
-3,721
-0.2% -$135K 0.29% 61
2020
Q4
$54.8M Buy
1,488,409
+38,186
+3% +$1.41M 0.32% 61
2020
Q3
$53.2M Buy
1,450,223
+123,273
+9% +$4.52M 0.36% 52
2020
Q2
$43.4M Buy
1,326,950
+18,602
+1% +$608K 0.33% 56
2020
Q1
$42.7M Buy
1,308,348
+234,179
+22% +$7.64M 0.41% 46
2019
Q4
$42.1M Buy
1,074,169
+66,003
+7% +$2.59M 0.33% 57
2019
Q3
$36.2M Buy
1,008,166
+12,706
+1% +$457K 0.32% 62
2019
Q2
$43.1M Buy
995,460
+61,005
+7% +$2.64M 0.4% 43
2019
Q1
$39.7M Sell
934,455
-89,834
-9% -$3.82M 0.38% 41
2018
Q4
$44.7M Buy
1,024,289
+90,438
+10% +$3.95M 0.49% 33
2018
Q3
$41.2M Buy
933,851
+13,910
+2% +$613K 0.39% 39
2018
Q2
$33.4M Sell
919,941
-24,479
-3% -$888K 0.35% 48
2018
Q1
$33.5M Buy
944,420
+117,617
+14% +$4.17M 0.38% 42
2017
Q4
$29.9M Buy
826,803
+10,868
+1% +$394K 0.35% 47
2017
Q3
$29.1M Buy
815,935
+12,634
+2% +$451K 0.39% 43
2017
Q2
$27M Buy
803,301
+11,942
+2% +$401K 0.4% 42
2017
Q1
$27.1M Buy
791,359
+49,842
+7% +$1.71M 0.46% 39
2016
Q4
$24.1M Buy
741,517
+8,078
+1% +$262K 0.45% 42
2016
Q3
$24.8M Buy
733,439
+45,220
+7% +$1.53M 0.46% 43
2016
Q2
$24.2M Buy
688,219
+57,060
+9% +$2.01M 0.51% 40
2016
Q1
$18.7M Buy
631,159
+33,880
+6% +$1M 0.42% 50
2015
Q4
$19.3M Buy
597,279
+15,833
+3% +$511K 0.46% 42
2015
Q3
$18.3M Buy
581,446
+4,090
+0.7% +$128K 0.52% 36
2015
Q2
$19.4M Buy
577,356
+60,602
+12% +$2.03M 0.54% 35
2015
Q1
$18M Buy
516,754
+10,431
+2% +$363K 0.51% 40
2014
Q4
$15.8M Sell
506,323
-22,030
-4% -$686K 0.49% 44
2014
Q3
$15.6M Buy
528,353
+25,730
+5% +$761K 0.46% 44
2014
Q2
$14.9M Buy
502,623
+81,157
+19% +$2.41M 0.52% 40
2014
Q1
$13.5M Buy
421,466
+7,249
+2% +$233K 0.51% 41
2013
Q4
$12.7M Buy
414,217
+36,312
+10% +$1.11M 0.52% 38
2013
Q3
$10.9M Sell
377,905
-36,486
-9% -$1.05M 0.48% 44
2013
Q2
$11.6M Buy
+414,391
New +$11.6M 0.59% 33